| 6/25/2008 | BKCVHY | Alpharma says cash slated for possible share repurchases, growth opportunities
|
| 2/20/2008 | BKCVHY | Alpharma says recent divestiture opened door to opportunities within remaining business segments
|
| 5/31/2007 | CVHY | Alpharma shifting focus toward growing revenues by making operational investments
|
| 3/23/2007 | BKCVHY | S&P rates Alpharma, convertibles B+
|
| 3/15/2007 | CVHY | Alpharma files automatic shelf registration
|
| 7/7/2006 | BKBTHY | S&P ups Alpharma
|
| 12/23/2005 | BTCVHY | Alpharma to redeem 8 5/8% notes, 3% convertibles
|
| 10/28/2005 | BKBTCVHY | Moody's affirms Alpharma
|
| 10/21/2005 | BKBTCVHY | S&P ups Alpharma outlook to stable
|
| 4/13/2005 | BKCVHY | Moody's affirms Alpharma
|
| 10/12/2004 | BKHY | S&P: Alpharma unaffected
|
| 8/18/2004 | BKCVHY | S&P: Alpharma unaffected
|
| 8/9/2004 | BKDDHY | S&P cuts Alpharma ratings
|
| 6/3/2004 | BKCVHY | Moody's upgrades Alpharma
|
| 11/19/2003 | BKCVHY | S&P cuts Alpharma ratings
|
| 4/16/2003 | BKCVHY | Moody's rates CMS bank facilities B2
|
| 4/16/2003 | HY | New Issue: Alpharma prices upsized $220 million eight-year notes to yield 8 5/8%
|
| 4/16/2003 | HY | Market Commentary: Equistar prices upsized $450 million; Levi descends more, Better Minerals soars on sale of unit
|
| 4/15/2003 | HY | Market Commentary: Four deals price as market stays hot; Levi Strauss plunges on tax allegations, Charter up
|
| 4/15/2003 | HY | Alpharma eight-year notes upsized to $220 million, talked at 83/4%-9%
|
| 4/8/2003 | HY | Alpharma starts roadshow for $200 million seven-year notes
|
| 4/8/2003 | HY | Market Commentary: Market mostly range-bound, though airlines, power off; Park Place split-rated deal prices
|
| 2/26/2003 | HY | Moody's upgrades Chesapeake, rates notes Ba3, converts B3
|
| 2/18/2003 | HY | Moody's raises BSkyB outlook
|
| 9/3/2002 | HY | Moody's cuts Aquila to junk
|
| 7/30/2002 | HY | Fitch lowers Williams Cos.
|
| 7/3/2002 | HY | Moody's puts Qwest on review
|
| 6/10/2002 | HY | Moody's puts Riverwood's ratings on review
|
